Pegavision (Polymacon) Daily Disposable Soft (Hydrophilic) Contact Lenses; Pegavision (Polymacon) Soft (Hydrophilic) Contact Lenses; Pegavision (Polymacon) Color Daily Disposable Soft (Hydrophilic) Contact Lenses; Pegavision (Polymacon) Color Soft (Hydrophilic) Contact Lenses
Pegavision Corporation · Decision date May 21, 2026
What did the FDA decide?
FDA records K253352 as a 510(k) premarket notification, with a decision dated May 21, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Ophthalmic
- Decision date
- May 21, 2026
Regulatory record facts
- Identifier
- K253352
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Pegavision Corporation
- Product code
- LPL
- Decision code
- SESE
- Decision date
- May 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Lenses, Soft Contact, Daily Wear.
- Applicant
- Pegavision Corporation
- Product code
- LPL
- FDA device class
- 2
FDA decision timeline
K253352 received
Application receipt date recorded by FDA.
K253352 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LPL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| St. shine Optical Co., Ltd. | 510(k) clearance | Oct 28, 2026 | FDA | |
| Visco Vision, Inc. | 510(k) clearance | Oct 23, 2026 | FDA | |
| Bausch + Lomb, Inc. | 510(k) clearance | Oct 16, 2026 | FDA | |
| Menicon Co, Ltd. | 510(k) clearance | Sep 17, 2026 | FDA | |
| INTEROJO, Inc. | 510(k) clearance | May 29, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Pegavision Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Taoyuan City
Sources and methodology
- Original FDA record: K253352
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


